Administration of mBD-14 to the skin lesions of AD mice also markedly decreased the number of CD4+ T cells (Supplemental Figure 7D) and tended to reduce the mast cell number, although this effect was not significant (Supplemental Figure 7E). Here, CD4 is linked to Alzheimer disease.